2023 (v1)
Publication
No description
Uploaded on: February 11, 2024
M
S
Last name: MERLER
First name: Sara
No description
: Introduction: The Meet-URO 18 study is a multicentric study of patients with metastatic renal cell carcinoma receiving nivolumab in the second-line and beyond, categorized as responders (progression-free survival ≥ 12 months) and non-responders (progression-free survival < 3 months). Areas covered: The current study includes extensive...